An Efficient Development Paradigm for Biosimilars Christopher J. WebsterAnny C. WongGillian R. Woollett Current Opinion Open access 06 August 2019 Pages: 603 - 611
Different Cardiotoxicity of Palbociclib and Ribociclib in Breast Cancer: Gene Expression and Pharmacological Data Analyses, Biological Basis, and Therapeutic Implications Matteo SantoniGiulia OcchipintiNicola Battelli Current Opinion 16 September 2019 Pages: 613 - 620
Evolution of the EU Biosimilar Framework: Past and Future Elena Wolff-HolzKlara TiitsoMartina Weise Review Article Open access 20 September 2019 Pages: 621 - 634
Extrapolation in Practice: Lessons from 10 Years with Biosimilar Filgrastim Pere GasconAndriy KrendyukovMatti Aapro Review Article Open access 22 August 2019 Pages: 635 - 645
CAR-T Engineering: Optimizing Signal Transduction and Effector Mechanisms Emiliano RoselliJeremy S. FrielingDaniel Abate-Daga Review Article 24 September 2019 Pages: 647 - 659
Assessment of the Molecular Mechanism of Action of SB3, a Trastuzumab Biosimilar Kyungyeol PaekGo-woon KimJae Hee Lee Original Research Article Open access 23 September 2019 Pages: 661 - 671
Steady-State Plasma Concentrations of Polyethylene Glycol (PEG) are Reached in Children and Adults During Once-Weekly Prophylactic Treatment with Nonacog Beta Pegol (N9-GP) Ola SternebringCharlotte Gabel-JensenInga Bjørnsdottir Original Research Article Open access 23 September 2019 Pages: 673 - 681
Analysis of Immunogenicity Data in the Product Information of Biological Drugs: A Need to Report Immunogenicity Data Systematically Rodrigo BorregaJoao Paulo CruzJoao Goncalves Original Research Article 08 October 2019 Pages: 683 - 691
Biosimilars: An Opportunity to Update the Product Information of Biological Drugs Regarding their Immunogenicity Rodrigo BorregaJoao Paulo CruzJoao Goncalves Letter to the Editor 25 October 2019 Pages: 693 - 695
